
What's is new?
SCIENCE & INNOVATION
Driving Change for People With Cancer and Rare Disease.
Advancing research and improving outcomes for cancer and rare disease patients.
OUR PIPELINE
Treating the Untreatable.
Developing innovative therapies to address unmet medical needs and provide options for patients with limited or no effective treatments.

Since its early development, Genventis has focused on neuropathic pain, leaving nociceptive pain relatively overlooked and patients with limited treatment options.
THE GENVENTIS DIFFERENCE
Focused on improving patients’ lives through scientific innovation and research.
Advancing innovative oncology research focused on developing future therapies for patients with difficult cancers worldwide.
The Future with GVT
GVT is designed to make waves in helping patients with untreatable nociceptive pain and other diseases of undesired neural activity. The journey is just beginning!
ABOUT US
We are an R&D driven, AI-powered biopharmaceutical company.
An R&D-driven, AI-powered biopharmaceutical company advancing innovative therapies through data and technology.
Who We Are
Boosting anti-tumor responses by combining foundational cancer treatments with negative immune regulators that play different roles in adjusting the immune response.

A CULTURE OF CURIOSITY
Patient Driven, Lasting Impact.
Driving Better Outcomes for Patients and Healthcare Professionals


Healthcare professionals
Using science to make a difference in patients’ lives

Patients
Incorporating the patient perspective

Partnerships
Partnering with industry leaders and innovators
ENVIRONMENTAL, SOCIAL AND GOVERNANCE
We make an impact that lasts.
Our impact is built to last. By leading with purpose, we make courageous decisions that improve lives and create lasting value for patients, families, and our people.

Environmental, Social & Governance (ESG)
Find out how we're supporting the future of our business and the well-being of patients, people, and communities around the world.
Media
Our latest news, announcements and multimedia resources
Sustainability
Our science-led strategy is key to delivering long-term value for patients, employees, and shareholders.





